Patients Labeled “Non-Urgent” By Emergency Rooms May Still Need Hospitalization: Study

New research suggests that many patients labeled as “non-urgent” in the emergency room actually still receive diagnostic testing and end up hospitalized due to their injuries. 

In a study published by the medical journal JAMA Internal Medicine on April 18, researchers from the University of California found that four out of every 100 patients labeled non-urgent in triage were later admitted to the hospital.

In addition, many patients who arrive at emergency rooms (ERs) and are given a non-urgent status still end up undergoing diagnostic scans, imaging and other testing.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Some states have policies in place that charge a copayment for patients with Medicaid insurance who go to the ER for non-urgent visits, a policy that may keep many people from seeking needed care.

Researchers analyzed data from the National Hospital Ambulatory Medical Care Survey, a survey that focused on patient visits to the ER. They focused on more than 60,000 patients ages 18 to 64 from 2009 to 2011, representing over 240 million ER visits.

The study found that half of non-urgent visits involved diagnostic scans, imaging or blood tests, to help diagnose the problem; while one-third of visits involved procedures like splinting or giving intravenous fluids.

For urgent visits, three-quarters involved diagnostics and more than half involved other procedures.

The study also concluded that six out of 10 of the most common diagnoses were the same between urgent and non-urgent patients. Those included, backache, acute upper respiratory infections, soft-tissue inflammation, and acute sore throat.

Some of the procedures and testing may not have needed to occur in an ER setting, but since patients went to the ER, that is where they were treated.

Health experts say triage was never intended to completely rule out severe illness, only to offer patients an estimate of how long they may have to wait to see a doctor and prioritize the patients who most urgently need to be seen. The triage system was not designed to be perfect, they warn.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted yesterday)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 2 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 3 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.